PACAP-38 (16-38), human, mouse, rat
CAS No. 144025-82-1
PACAP-38 (16-38), human, mouse, rat ( —— )
产品货号. M30318 CAS No. 144025-82-1
PACAP-38 (16-38), human, mouse, rat demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY and catecholamine production.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PACAP-38 (16-38), human, mouse, rat
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PACAP-38 (16-38), human, mouse, rat demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY and catecholamine production.
-
产品描述PACAP-38 (16-38), human, mouse, rat demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY and catecholamine production.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number144025-82-1
-
分子量2720.3
-
分子式C123H215N39O28S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称Sequence:{Gln}{Met}{Ala}{Val}{Lys}{Lys}{Tyr}{Leu}{Ala}{Ala}{Val}{Leu}{Gly}{Lys}{Arg}{Tyr}{Lys}{Gln}{Arg}{Val}{Lys}{Asn}{Lys}-NH2
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Braas KM, et al. Pituitary adenylate cyclase-activating polypeptides, PACAP-38 and PACAP-27, regulation of sympathetic neuron catecholamine, and neuropeptide Y expression through activation of type I PACAP/VIP receptor isoforms. Ann N Y Acad Sci. 1996 Dec 26;805:204-16.
产品手册
关联产品
-
Dihydrophaseic acid ...
The fruits of Zanthoxylum bungeanum.
-
OVA Peptide 257-264 ...
OVA Peptide 257-264 (2TFA) is an ovalbumin octamer Peptide expressed by class I MHC molecule h-2kb.
-
L-Asparaginase
L-Asparaginase (L-?ASNase), a hydrolase that catalyzes the conversion of L-asparagine, used in acute lymphoblastic leukemia treatment.Asparaginase is an enzyme that is used as a medication. As a medication, L-asparaginase is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin.